Cannabis business operators and advisors have spent the last several years watching the market evolve from a THC-and-CBD story into something much more nuanced: the rise of the minor cannabinoid economy. As product categories mature and consumers become more sophisticated, demand is shifting toward non-intoxicating isolates and compounds that have specific therapeutic potential. This increased demand is creating a supply-chain bottleneck in the manufacturing vertical market segment.

More From Rolling Stone